Andetta Rotilla Hunsaker, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Embolism | 22 | 2023 | 2540 | 1.810 |
Why?
|
Tomography, X-Ray Computed | 38 | 2024 | 20499 | 1.390 |
Why?
|
Angiography | 13 | 2021 | 1598 | 1.360 |
Why?
|
Multiple Pulmonary Nodules | 3 | 2024 | 167 | 1.150 |
Why?
|
Venous Thrombosis | 3 | 2023 | 1292 | 0.990 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2021 | 270 | 0.950 |
Why?
|
Pulmonary Artery | 9 | 2021 | 1916 | 0.830 |
Why?
|
Emphysema | 2 | 2022 | 240 | 0.830 |
Why?
|
Pulmonary Emphysema | 4 | 2022 | 688 | 0.820 |
Why?
|
Lung Neoplasms | 8 | 2024 | 13268 | 0.670 |
Why?
|
Foreign Bodies | 2 | 2016 | 397 | 0.620 |
Why?
|
Hypertrophy, Right Ventricular | 3 | 2013 | 105 | 0.610 |
Why?
|
Heart Neoplasms | 2 | 2011 | 360 | 0.610 |
Why?
|
Ventricular Dysfunction, Right | 3 | 2021 | 615 | 0.540 |
Why?
|
Radiography, Thoracic | 6 | 2020 | 1296 | 0.540 |
Why?
|
Intubation | 1 | 2016 | 139 | 0.530 |
Why?
|
Mediastinal Neoplasms | 1 | 2019 | 402 | 0.520 |
Why?
|
Heart Ventricles | 8 | 2021 | 3806 | 0.510 |
Why?
|
Early Detection of Cancer | 4 | 2022 | 3164 | 0.500 |
Why?
|
Diagnostic Imaging | 4 | 2016 | 3524 | 0.440 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 411 | 0.440 |
Why?
|
Risk Management | 1 | 2016 | 557 | 0.420 |
Why?
|
Hypertension, Pulmonary | 1 | 2023 | 1565 | 0.400 |
Why?
|
Preoperative Care | 3 | 2017 | 2246 | 0.390 |
Why?
|
Thoracic Wall | 2 | 2011 | 199 | 0.380 |
Why?
|
Catheterization | 1 | 2016 | 1426 | 0.370 |
Why?
|
Observer Variation | 4 | 2014 | 2599 | 0.370 |
Why?
|
Physical Examination | 1 | 2017 | 1245 | 0.360 |
Why?
|
Thoracic Diseases | 1 | 2011 | 99 | 0.360 |
Why?
|
Radiation Dosage | 4 | 2014 | 1957 | 0.330 |
Why?
|
Incidental Findings | 1 | 2014 | 693 | 0.330 |
Why?
|
Thrombosis | 1 | 2023 | 2931 | 0.320 |
Why?
|
Outpatients | 1 | 2017 | 1590 | 0.320 |
Why?
|
Iodine | 1 | 2010 | 286 | 0.300 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1201 | 0.290 |
Why?
|
Surgical Sponges | 1 | 2007 | 39 | 0.290 |
Why?
|
Radiographic Image Enhancement | 2 | 2013 | 875 | 0.270 |
Why?
|
Phlebography | 1 | 2008 | 326 | 0.270 |
Why?
|
Lung | 10 | 2024 | 9973 | 0.270 |
Why?
|
Mediastinum | 2 | 2019 | 267 | 0.250 |
Why?
|
Radiography | 1 | 2016 | 6956 | 0.250 |
Why?
|
Lung Diseases | 1 | 2015 | 1908 | 0.250 |
Why?
|
Pneumonectomy | 3 | 2002 | 1110 | 0.240 |
Why?
|
Image Enhancement | 3 | 2010 | 2880 | 0.230 |
Why?
|
Thorax | 1 | 2007 | 553 | 0.230 |
Why?
|
Risk Assessment | 7 | 2021 | 23816 | 0.230 |
Why?
|
Lymph Nodes | 2 | 2014 | 3470 | 0.220 |
Why?
|
Hemorrhage | 1 | 2015 | 3399 | 0.220 |
Why?
|
Pelvis | 1 | 2008 | 732 | 0.220 |
Why?
|
Models, Anatomic | 2 | 2017 | 679 | 0.210 |
Why?
|
Documentation | 1 | 2009 | 892 | 0.210 |
Why?
|
Intensive Care Units | 1 | 2016 | 3732 | 0.210 |
Why?
|
Ventilation-Perfusion Ratio | 2 | 2002 | 117 | 0.210 |
Why?
|
Acute Disease | 8 | 2021 | 7225 | 0.200 |
Why?
|
Radiopharmaceuticals | 2 | 2011 | 2634 | 0.200 |
Why?
|
Reproducibility of Results | 11 | 2023 | 20037 | 0.200 |
Why?
|
Diagnosis, Differential | 7 | 2011 | 12951 | 0.200 |
Why?
|
Predictive Value of Tests | 9 | 2023 | 15207 | 0.190 |
Why?
|
Artifacts | 1 | 2009 | 1894 | 0.180 |
Why?
|
Retrospective Studies | 21 | 2024 | 79984 | 0.180 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2014 | 1214 | 0.180 |
Why?
|
Humans | 55 | 2024 | 757566 | 0.180 |
Why?
|
Lower Extremity | 1 | 2008 | 1188 | 0.170 |
Why?
|
Thoracic Neoplasms | 2 | 2017 | 265 | 0.170 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 2167 | 0.160 |
Why?
|
Middle Aged | 29 | 2022 | 219192 | 0.150 |
Why?
|
Cysts | 1 | 2023 | 681 | 0.150 |
Why?
|
Positron-Emission Tomography | 2 | 2011 | 6457 | 0.140 |
Why?
|
Sensitivity and Specificity | 9 | 2013 | 14637 | 0.140 |
Why?
|
Thyroid Nodule | 1 | 2024 | 760 | 0.140 |
Why?
|
Radiology Department, Hospital | 1 | 2020 | 405 | 0.130 |
Why?
|
Male | 33 | 2022 | 358180 | 0.130 |
Why?
|
Female | 32 | 2022 | 389943 | 0.130 |
Why?
|
Aged | 21 | 2021 | 167890 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2003 | 910 | 0.120 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 538 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2020 | 58558 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 6 | 2017 | 36270 | 0.110 |
Why?
|
Intraoperative Care | 1 | 2016 | 764 | 0.100 |
Why?
|
Precancerous Conditions | 1 | 2019 | 977 | 0.100 |
Why?
|
Contrast Media | 5 | 2012 | 5297 | 0.100 |
Why?
|
Pleural Neoplasms | 2 | 2008 | 609 | 0.090 |
Why?
|
Sarcoidosis | 1 | 1996 | 520 | 0.090 |
Why?
|
Uncertainty | 1 | 2015 | 750 | 0.090 |
Why?
|
Adult | 19 | 2021 | 219725 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2020 | 2212 | 0.090 |
Why?
|
Radiation Protection | 2 | 2013 | 424 | 0.080 |
Why?
|
Body Burden | 1 | 2009 | 158 | 0.080 |
Why?
|
Ventricular Function, Right | 1 | 2013 | 609 | 0.080 |
Why?
|
Heart Diseases | 2 | 2016 | 2781 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2013 | 1177 | 0.080 |
Why?
|
Radiography, Interventional | 1 | 2015 | 1112 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3415 | 0.080 |
Why?
|
Pleural Diseases | 1 | 2008 | 137 | 0.070 |
Why?
|
Respiratory Function Tests | 2 | 2021 | 1680 | 0.070 |
Why?
|
Sarcoma | 1 | 2017 | 1784 | 0.070 |
Why?
|
Patient Care Planning | 1 | 2011 | 906 | 0.070 |
Why?
|
Natural Language Processing | 1 | 2014 | 1135 | 0.060 |
Why?
|
Thoracotomy | 1 | 2007 | 363 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1159 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6152 | 0.060 |
Why?
|
Young Adult | 6 | 2020 | 58755 | 0.060 |
Why?
|
Consensus | 2 | 2024 | 3097 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2010 | 2357 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7366 | 0.050 |
Why?
|
Disease Management | 1 | 2013 | 2495 | 0.050 |
Why?
|
Hemodynamics | 1 | 2013 | 4156 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3077 | 0.050 |
Why?
|
Hematoma | 1 | 2007 | 768 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3197 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12047 | 0.050 |
Why?
|
Echocardiography | 2 | 2021 | 4963 | 0.050 |
Why?
|
Comorbidity | 3 | 2015 | 10477 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1890 | 0.050 |
Why?
|
Hemangiosarcoma | 1 | 2003 | 216 | 0.050 |
Why?
|
Risk Factors | 5 | 2020 | 73708 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2013 | 3579 | 0.040 |
Why?
|
Algorithms | 4 | 2023 | 13952 | 0.040 |
Why?
|
Adolescent | 4 | 2020 | 87819 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6323 | 0.040 |
Why?
|
Logistic Models | 1 | 2014 | 13221 | 0.040 |
Why?
|
Goals | 1 | 2005 | 707 | 0.040 |
Why?
|
Biopsy | 1 | 2011 | 6757 | 0.040 |
Why?
|
Massachusetts | 2 | 2013 | 8815 | 0.040 |
Why?
|
Stroke Volume | 1 | 2013 | 5461 | 0.040 |
Why?
|
Lung Transplantation | 1 | 2008 | 1306 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 420 | 0.040 |
Why?
|
Organ Size | 2 | 2013 | 2248 | 0.040 |
Why?
|
Survival Rate | 3 | 2021 | 12684 | 0.040 |
Why?
|
Prognosis | 5 | 2021 | 29488 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2023 | 891 | 0.040 |
Why?
|
Patient Selection | 2 | 2001 | 4235 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 2 | 2017 | 4046 | 0.040 |
Why?
|
Mesothelioma | 1 | 2003 | 807 | 0.030 |
Why?
|
Airway Resistance | 1 | 1998 | 400 | 0.030 |
Why?
|
Ultrasonography | 2 | 2024 | 5951 | 0.030 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 1996 | 45 | 0.030 |
Why?
|
Prevalence | 2 | 2015 | 15640 | 0.030 |
Why?
|
Pulmonary Veins | 1 | 2021 | 745 | 0.030 |
Why?
|
Spirometry | 1 | 1998 | 923 | 0.030 |
Why?
|
Cohort Studies | 3 | 2020 | 41190 | 0.030 |
Why?
|
Lymphatic Diseases | 1 | 1996 | 320 | 0.030 |
Why?
|
Soft Tissue Neoplasms | 1 | 2003 | 1152 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15781 | 0.030 |
Why?
|
Boston | 2 | 2020 | 9298 | 0.030 |
Why?
|
United States | 4 | 2021 | 71902 | 0.030 |
Why?
|
Curriculum | 1 | 2005 | 3715 | 0.020 |
Why?
|
Radiology | 1 | 2005 | 2101 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4760 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 29712 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2003 | 3217 | 0.020 |
Why?
|
Tracheal Diseases | 1 | 2008 | 115 | 0.020 |
Why?
|
Iohexol | 1 | 2008 | 204 | 0.020 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2008 | 172 | 0.020 |
Why?
|
Bronchial Diseases | 1 | 2008 | 150 | 0.020 |
Why?
|
Neoplasms | 1 | 1996 | 21986 | 0.020 |
Why?
|
Lymphoma | 1 | 1996 | 1900 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3562 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39020 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2008 | 15532 | 0.020 |
Why?
|
Aneurysm, False | 1 | 2008 | 254 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4760 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 1996 | 4886 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 39811 | 0.020 |
Why?
|
Internship and Residency | 1 | 2005 | 5854 | 0.010 |
Why?
|
Competency-Based Education | 1 | 2005 | 218 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3670 | 0.010 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 2001 | 66 | 0.010 |
Why?
|
Least-Squares Analysis | 1 | 2001 | 369 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1121 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8600 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2001 | 1976 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10634 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2001 | 6230 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1996 | 20992 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2012 | 64242 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 2001 | 14473 | 0.000 |
Why?
|
Child, Preschool | 1 | 2004 | 42045 | 0.000 |
Why?
|